Clinical trial

Effects of Dapagliflozin on Cardiorespiratory Parameters in Heart Failure

NCT05770167

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2022-05-06

PhaseN/A

Study timeline

Study start (actual)2022-05-06Date precision: day

Registry last updated2023-03-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Heart Failureunresolved

Heart Failure With Reduced Ejection Fractionunresolved

Left Ventricle Remodelingunresolved

Sleep Apneaunresolved

Cardiopulmonary Exercise Testunresolved

Interventions

Sponsors & collaborators

Centro Cardiologico Monzinolead sponsor

Mapped research locations

MilanItaly1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05770167 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.